Romstim 125mcg Injection

Romstim 125mcg Injection belongs to the platelet-stimulating agent category and contains Romiplostim. It is used to treat immune primary thrombocytopenia (ITP), a condition in which the body's immune system mistakenly destroys its own platelets, leading to low platelet counts. This medicine is mainly prescribed for adults and children aged 18 years and above when other treatments have not worked. It is generally recommended when immunoglobulins, corticosteroids, or splenectomy have failed to improve platelet levels. This treatment purpose applies to lower-strength formulations as well, which are used for the same therapeutic indication with dose adjustments based on platelet response.

This drug is contraindicated in individuals with known hypersensitivity to Romiplostim or medicines produced using E. coli-based DNA technology. Before receiving this injection, inform your physician if you have liver disorders, cancer, a recent surgery, smoking habits, or if you are taking birth control pills. These factors can influence the medication's effectiveness and safety, helping your physician determine if adjustments are necessary.

During treatment, your physician will conduct regular blood tests to check for abnormalities that may indicate bone marrow changes. Romiplostim has been associated with significant bone marrow alterations, so ongoing monitoring is essential. Based on test results, your doctor may decide whether to continue or discontinue therapy.

The medication is not recommended during pregnancy unless clearly advised by your doctor. If pregnant, planning pregnancy, or suspecting pregnancy, you must inform your physician. Since it is unknown whether the drug passes into breast milk, breastfeeding should be avoided.

Awareness of potential side effects is important, which may include headache, dizziness, bone pain, or injection-site reactions. If Romstim is not suitable, your doctor may recommend alternative agents that provide similar therapeutic effects.

Treatment of immune thrombocytopenia (ITP)

Romstim 125mcg Injection works by stimulating the production of platelets in the bone marrow. It binds to and activates the thrombopoietin receptor, which promotes the development and maturation of platelets. This helps to increase the platelet count in individuals with ITP.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Loss of response Progression of Myelodysplastic Syndromes Thromboembolic complications Leukemia Higher risk of blood clots Common Headache, dizziness Allergic reaction Upper respiratory tract infection Joint pain, muscle pain Indigestion Sleeping trouble Tingling or numbness of the feet or hands Abdominal pain, diarrhoea, and indigestion Fever, cough